Prospects for new drugs and regimens in the treatment of tuberculosis
Since rifampicin was introduced in 1967, no novel compounds have been approved for first-line chemotherapy of tuberculosis.The inexorable rise in cases of tuberculosis worldwide, fuelled by the HIV epidemic, highlights the need for new drugs, particularly those that can shorten the duration of treat...
Saved in:
| Main Authors: | , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
2014
|
| 在線閱讀: | http://www.scopus.com/inward/record.url?eid=2-s2.0-57049166987&partnerID=40&md5=985d5ea7dc7097a63cc1ad12f950161b http://cmuir.cmu.ac.th/handle/6653943832/2299 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 機構: | Chiang Mai University |
| 語言: | English |